Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1305
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00657267 | Dose-Intense Temozolomide in Recurrent Glioblastoma | ||
| NCT04732065 | ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors | ||
| NCT00856050 | Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma | ||
| NCT07513324 | Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0) | ||
| NCT01841879 | Mumbai Worksite Tobacco Control Study | ||
| NCT07123090 | A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma | ||
| NCT02658279 | Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype | ||
| NCT00790010 | Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma | ||
| NCT00299767 | Phase I Study of Sequential Cord Blood Transplants | ||
| NCT00133367 | Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus | ||
| NCT00258687 | Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma | ||
| NCT01196936 | Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors | ||
| NCT00006107 | Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | ||
| NCT01340300 | Exercise and Metformin in Colorectal and Breast Cancer Survivors | ||
| NCT01024387 | AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors | ||
| NCT03341936 | Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN | ||
| NCT03974217 | Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts | ||
| NCT04775550 | DARA RVD For High Risk SMM | ||
| NCT03595917 | ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML | ||
| NCT01983410 | A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma | ||
| NCT03735446 | Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial | ||
| NCT00142155 | Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia | ||
| NCT02852655 | A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma | ||
| NCT00165347 | Protein Tyrosine Kinases (PTK) in Multiple Myeloma | ||
| NCT03777410 | Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma | ||
| NCT01182415 | High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma | ||
| NCT02441140 | Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis | ||
| NCT01516216 | Study of Vitamin D in Untreated Metastatic Colorectal Cancer | ||
| NCT01288235 | Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation | ||
| NCT00251355 | Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer | ||
| NCT00806715 | Iron Overload in Stem Cell Transplant Recipients | ||
| NCT00831571 | Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin | ||
| NCT00165555 | Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma | ||
| NCT00729638 | RAD001 and Lenalidomide in the Treatment of Subjects With Relapsed and Relapsed/Refractory Multiple Myeloma | ||
| NCT02438358 | Feasibility Study of Intraoperative Imaging in Breast Cancer | ||
| NCT02666209 | Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple Myeloma | ||
| NCT07519200 | Sexual Health and Rehabilitation for Women With Metastatic Breast Cancer (SHARE-MC): An Educational Intervention | ||
| NCT06518551 | Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM | ||
| NCT02123966 | An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease | ||
| NCT01574937 | XL-184+Abiraterone in Post-Chemo CRPC | ||
| NCT00144703 | Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation | ||
| NCT00459069 | The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma | ||
| NCT00165373 | rhEndostatin Protein Involving Pediatric Patients With Cancer | ||
| NCT05176288 | Avelumab, Palbociclib and Axitinib in Advanced RCC | ||
| NCT06677190 | Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin | ||
| NCT03728426 | Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection | ||
| NCT00130689 | Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer | ||
| NCT03249090 | Electronic Patient Reporting of Symptoms During Cancer Treatment | ||
| NCT06923397 | Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial | ||
| NCT01323920 | Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors |
